CRAWFORD & CO
Datakwaliteit: 100%
CRD-B
NYSE
Financial Services
Insurance Agents & Brokers
€ 10,17
▼
€ 0,37
(-3,51%)
Marktkapitalisatie: 540,51 M
Prijs
€ 10,54
Marktkapitalisatie
540,51 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Revenue grew 3,57% annually over 5 years — modest growth
Earnings declined -26,18% over the past year
ROE of 10,78% — decent returns on equity
Debt/Equity of 0,11 — conservative balance sheet
Generating 94,83 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 5,82%
Groei
Revenue Growth (5Y)
3,57%
Onder sectorgemiddelde (5,83%)
Revenue (1Y)-2,25%
Earnings (1Y)-26,18%
FCF Growth (3Y)-2,08%
Kwaliteit
Return on Equity
10,78%
Boven sectorgemiddelde (9,24%)
ROICN/A
Net Margin1,50%
Op. MarginN/A
Veiligheid
Debt / Equity
0,11
Onder sectorgemiddelde (0,49)
Current Ratio1,36
Interest CoverageN/A
Waardering
PE (TTM|2027)
27,53 | 9,29
Boven sectorgemiddelde (11,14)
P/B Ratio2,89
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Financial Services sector mediaan (2607 peers)
Sectorvergelijking
vs Financial Services sector mediaan (2607 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 27,5 | 11,1 |
| P/B | 2,9 | 1,2 |
| ROE % | 10,8 | 9,2 |
| Net Margin % | 1,5 | 9,4 |
| Rev Growth 5Y % | 3,6 | 5,8 |
| D/E | 0,1 | 0,5 |
Koersdoel Analisten
1 analist
Buy
Huidig
€ 10,17
Koersdoel
€ 14,00
€ 14,00
€ 14,00
€ 14,00
Vooruitzicht
Forward K/W
8,96
Forward WPA
€ 1,14
WPA Groei (sch.)
+10,7%
Omzet Sch.
1,37 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 1,14
€ 1,12 – € 1,15
|
1,37 B | 2 |
| FY2026 |
€ 1,03
€ 1,00 – € 1,05
|
1,31 B | 2 |
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| 2026 Q2 |
€ 0,28
€ 0,26 – € 0,29
|
334,00 M | 2 |
| 2026 Q1 |
€ 0,23
€ 0,22 – € 0,24
|
313,82 M | 2 |
Winstverassingen
Laatste 4 kwartalen
| Kwartaal | Geschat WPA | Werkelijk WPA | Verrassing |
|---|---|---|---|
| Q42025 | € 0,26 | € 0,15 | -42,3% |
| Q32025 | € 0,29 | € 0,32 | +10,3% |
| Q22025 | € 0,25 | € 0,22 | -10,2% |
| Q12025 | € 0,20 | € 0,21 | +5,0% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2,25% | Revenue Growth (3Y) | -0,23% |
| Earnings Growth (1Y) | -26,18% | Earnings Growth (3Y) | -19,91% |
| Revenue Growth (5Y) | 3,57% | Earnings Growth (5Y) | -10,57% |
| Profitability | |||
| Revenue (TTM) | 1,31 B | Net Income (TTM) | 19,63 M |
| ROE | 10,78% | ROA | 2,46% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | 1,50% | Free Cash Flow (TTM) | 94,83 M |
| ROIC | N/A | FCF Growth (3Y) | -2,08% |
| Safety | |||
| Debt / Equity | 0,11 | Current Ratio | 1,36 |
| Interest Coverage | N/A | Asset Turnover | 1,64 |
| Working Capital | 97,40 M | Tangible Book Value | 41,94 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 27,53 | Forward P/E | N/A |
| P/B Ratio | 2,89 | P/S Ratio | 0,41 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 17,55% | ||
| Market Cap | 540,51 M | Enterprise Value | 493,02 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | 25,56 |
| FCF / Share | 1,85 | OCF / Share | 1,99 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0,54% | FCF Conversion | 483,00% |
| SBC-Adj. FCF | 89,01 M | Growth Momentum | -5,82 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,31 B | 1,34 B | 1,32 B | 1,23 B | 1,14 B |
| Net Income | 19,63 M | 26,60 M | 30,61 M | -18,31 M | 30,69 M |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | 294,17 M | 299,66 M | 286,51 M | 255,75 M | 244,85 M |
| D&A | 40,04 M | 36,20 M | 35,74 M | 36,10 M | 40,18 M |
| Interest Expense | 14,69 M | 16,86 M | 17,04 M | 10,31 M | 6,56 M |
| Income Tax | 14,92 M | 14,58 M | 17,10 M | 23,58 M | 13,32 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 764,30 M | 803,76 M | 799,20 M | 791,51 M | 852,64 M |
| Total Liabilities | — | — | — | — | — |
| Shareholders' Equity | 173,09 M | 157,21 M | 141,62 M | 124,54 M | 211,97 M |
| Total Debt | 227,50 M | 235,80 M | 223,81 M | 265,65 M | 185,30 M |
| Cash & Equivalents | 64,08 M | 55,41 M | 58,36 M | 46,01 M | 53,23 M |
| Current Assets | 352,41 M | 374,23 M | 369,35 M | 351,27 M | 345,92 M |
| Current Liabilities | 309,57 M | 299,73 M | 299,29 M | 279,49 M | 303,86 M |
{"event":"ticker_viewed","properties":{"ticker":"CRD-B","listing_kind":"stock","pathname":"/stocks/crd-b","exchange":"NYSE","country":"US"}}